MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
13.53
-0.39
-2.80%
Opening 09:36 05/13 EDT
OPEN
13.50
PREV CLOSE
13.92
HIGH
13.55
LOW
13.38
VOLUME
11.66K
TURNOVER
--
52 WEEK HIGH
21.87
52 WEEK LOW
11.51
MARKET CAP
2.36B
P/E (TTM)
62.61
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HCM last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at HCM last week (0428-0502)?
Weekly Report · 05/05 09:26
Weekly Report: what happened at HCM last week (0421-0425)?
Weekly Report · 04/28 09:28
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025
Barchart · 04/23 19:00
Reported Earlier, HUTCHMED Wraps Enrollment In Phase II Gastric Cancer Trial For Savolitinib, Targets Late 2025 China Filing
Benzinga · 04/22 05:33
HUTCHMED Completes Enrollment in Phase II Trial of Savolitinib for Gastric Cancer Patients with MET Amplification
NASDAQ · 04/22 00:10
HUTCHMED COMPLETES PATIENT ENROLLMENT OF A PHASE II REGISTRATION STUDY OF SAVOLITINIB IN GASTRIC CANCER IN CHINA
Reuters · 04/22 00:00
Weekly Report: what happened at HCM last week (0414-0418)?
Weekly Report · 04/21 09:29
More
About HCM
More
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.
Recently
Symbol
Price
%Change

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.